The DAF-19 antibody refers to polyclonal antibodies generated to detect specific isoforms of the DAF-19 transcription factor. Two primary antibodies were developed:
AbDAF19N: Targets the N-terminal region (amino acids 2–212) and detects a 120 kDa band on Western blots, corresponding to DAF-19A/B isoforms .
AbDAF19C: Targets the C-terminal region (amino acids 340–513) but is unsuitable for Western blotting .
Both antibodies localize DAF-19 to neuronal nuclei and hypodermal cells in C. elegans, aiding in the study of its developmental and immune functions .
DAF-19 collaborates with ATF-7 (a CREB/ATF-family transcription factor) to regulate:
Serotonin biosynthesis: Upregulates tph-1 in ADF chemosensory neurons during Pseudomonas aeruginosa infection .
Antimicrobial gene expression: Controls intestinal immune responses (e.g., T24B8.5, K08D8.5) against pathogens .
DAF-19 has three isoforms with distinct roles:
AbDAF19N confirmed isoform-specific expression patterns via immunostaining .
AbDAF19C revealed hypodermal expression during larval stages .
Evolutionary conservation: DAF-19’s interaction with ATF-7 mirrors RFX-CREB collaboration in human immune cells, suggesting ancient immune regulatory mechanisms .
Therapeutic potential: RFX transcription factors are linked to human ciliopathies, making DAF-19 a model for studying congenital disorders .
DAF-19 is a transcription factor potentially regulating gene expression in ciliated sensory neurons. While it may activate expression of shared components in sensory cilia, it does not appear to regulate cell-type-specific expression. In conjunction with the transcription factor ATF-7, DAF-19 is involved in modulating the serotonergic response of ADF neurons to pathogenic food sources.
DAF-19 Function and Related Studies: